Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...
Wednesday, the FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for the first-line treatment of adult patients with ...
Kremlin says Lebanon pager blasts risk igniting tensions in 'explosive' region Merck, a leading science and technology company, launched the first single-use reactor specifically designed to ...
We sit here today, we probably have one of the best Phase III pipelines we've had at our companies -- certainly, our recent history ... We received the approval. We're launching in Germany and Austria ...
In addition to Truist Financial, Merck & Company also received a Buy from Goldman Sachs’s Chris Shibutani in a report issued today. However, on August 29, Wells Fargo maintained a Hold rating on ...
The gross proceeds to the Company from the exercise of the Existing Warrants together with the sale of the new warrants is expected to be approximately $6.2 million. The closing of the transaction is ...